These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22872079)

  • 1. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
    Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
    Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide.
    Ma S; Ma CC
    Vascul Pharmacol; 2014 Nov; 63(2):63-70. PubMed ID: 25139660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
    Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
    Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic vascular protective effects of statins in perioperative medicine.
    Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
    Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW; Lefer DJ
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential benefit of statins for vascular disease in systemic sclerosis.
    Kuwana M
    Curr Opin Rheumatol; 2006 Nov; 18(6):594-600. PubMed ID: 17053504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
    Antoniades C; Bakogiannis C; Leeson P; Guzik TJ; Zhang MH; Tousoulis D; Antonopoulos AS; Demosthenous M; Marinou K; Hale A; Paschalis A; Psarros C; Triantafyllou C; Bendall J; Casadei B; Stefanadis C; Channon KM
    Circulation; 2011 Jul; 124(3):335-45. PubMed ID: 21730307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase.
    Kwok JM; Ma CC; Ma S
    Vascul Pharmacol; 2013 Jan; 58(1-2):21-30. PubMed ID: 23085091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and endothelial dysfunction.
    Larose E; Ganz P
    Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering.
    Margaritis M; Channon KM; Antoniades C
    Antioxid Redox Signal; 2014 Mar; 20(8):1198-215. PubMed ID: 24111702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
    Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
    J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of statins on endothelium and endothelial progenitor cell recruitment.
    Walter DH; Dimmeler S; Zeiher AM
    Semin Vasc Med; 2004 Nov; 4(4):385-93. PubMed ID: 15861319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
    Laufs U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and direct vascular actions.
    Mueck AO; Seeger H
    Panminerva Med; 2003 Mar; 45(1):1-6. PubMed ID: 12682615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins promote potent systemic antioxidant effects through specific inflammatory pathways.
    Shishehbor MH; Brennan ML; Aviles RJ; Fu X; Penn MS; Sprecher DL; Hazen SL
    Circulation; 2003 Jul; 108(4):426-31. PubMed ID: 12860913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis.
    Kalinowski L; Dobrucki IT; Malinski T
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):585-95. PubMed ID: 12512694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
    Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.